Rohto Pharmaceutical
4527.T
#4016
Rank
NZ$5.59 B
Marketcap
NZ$24.78
Share price
0.60%
Change (1 day)
3.03%
Change (1 year)

Operating Margin for Rohto Pharmaceutical (4527.T)

Operating Margin at the end of 2026: 14.00%

According to Rohto Pharmaceutical's latest financial reports and stock price the company's current Operating Margin is 13.99%. At the end of 2026 the company had an Operating Margin of 14.00%.

Operating Margin history for Rohto Pharmaceutical from 2008 to 2026

Operating Margin at the end of each year

Year Operating Margin Change
202614.00%1.45%
202513.80%-10.43%
202415.40%6.43%
202314.47%2.73%
202214.09%10.16%
202112.79%10.21%
202011.60%29.56%
20198.96%-9.31%
20189.87%2.54%
20179.63%10.79%
20168.69%-5.52%
20159.20%-10.23%
201410.25%-4.53%
201310.73%-9.68%
201211.88%-0.62%
201111.96%6.21%
201011.26%28.15%
20098.79%-26.62%
200811.97%

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.